Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial

Using tranexamic acid for an additional 24 hours postoperatively in hip and knee arthroplasty saves money: a cost analysis from the TRAC-24 randomized control trial

Aims: Tranexamic acid (TXA) is now commonly used in major surgical operations including orthopaedics. The TRAC-24 randomized control trial (RCT) aimed to assess if an additional 24 hours of TXA postoperatively in primary total hip (THA) and total knee arthroplasty (TKA) reduced blood loss. Contrary...

Full description

Bibliographic Details
Main Authors: Paul N. Karayiannis, Ashley Agus, Leanne Bryce, J. C. Hill, David Beverland
Format: Article
Language:English
Published: The British Editorial Society of Bone & Joint Surgery 2022-07-01
Series:Bone & Joint Open
Subjects:
cost analysis
tranexamic acid
hip arthroplasty
knee arthroplasty
randomized control trial
hip and knee arthroplasty
total knee arthroplasty (tka)
hip
blood loss
blood transfusions
primary total hip arthroplasty
saves
Online Access:https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.37.BJO-2021-0213.R1

Internet

https://online.boneandjoint.org.uk/doi/epdf/10.1302/2633-1462.37.BJO-2021-0213.R1

Similar Items